On Dec 8, 2020, National Medical Products Administration (NMPA) issued the draft Provisions on the Administration of the Drug Annual Report and the draft Templates for the Drug Annual Report for consultation, openly circulating for comments from the public until Dec 22, 2020. According to the consultation for Provisions on the Administration of the Drug […]
GVP Is Coming! NMPA Consults on the Draft GVP (Good Pharmacovigilance Practices).
On Dec 1, 2020, National Medical Products Administration (NMPA) issued the draft Good Pharmacovigilance Practices (GVP) for public consultation, openly circulating for comments from the public until Dec 18, 2020. The Pharmaceutical Administration Law of the People’s Republic of China has came into force on Dec 1, 2019. This regulation specifies that China will establish […]